Neonatal Mydriasis: Intravenous Lidocaine Adverse Reaction

@article{Berger2002NeonatalMI,
  title={Neonatal Mydriasis: Intravenous Lidocaine Adverse Reaction},
  author={Itai Berger and A. Steinberg and Y. Schlesinger and M. Seelenfreund and M. Schimmel},
  journal={Journal of Child Neurology},
  year={2002},
  volume={17},
  pages={400 - 401}
}
  • Itai Berger, A. Steinberg, +2 authors M. Schimmel
  • Published 2002
  • Medicine
  • Journal of Child Neurology
    • Lidocaine (a sodium channel blocker) serves as an antiepilepsy drug in neonates. We present a neonate with a seizure disorder who acutely developed pupillary mydriasis secondary to lidocaine overdose. We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed dilated pupils in neonates treated with lidocaine. (J Child Neurol 2002; 17:400-401). 
    View on SAGE
    ncbi.nlm.nih.gov
    8 Citations
    Highly Influencial Citations
    1
    Background Citations
    5
    8 Citations
    Citation Type

    Citation Type

    The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex
    • 13
    A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity.
    • 5
    Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment
    • 30
    Pharmacology Review: Lidocaine for Neonatal Seizure Management
    • 7
    Development of an optimal lidocaine infusion strategy for neonatal seizures
    • 64
    Intoxication néonatale à la lidocaïne après analgésie par bloc des nerfs honteux : à propos de trois observations
    • 12
    • Highly Influenced
    • PDF
    Outside the box: Medications worth considering when traditional antiepileptic drugs have failed
    • 7
    Gene expression profiling reveals the mechanism of action of anticonvulsant drug QYS
    • X. Li, Y. Hu
    • Biology, Medicine
    • Brain Research Bulletin
    • 2005
    • 11